Published on 13 Feb 2023 on Investing.com
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.11%
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.11%
Is a Surprise Coming for Sorrento Therapeutics (SRNEQ) This Earnings Season?
Investors are always looking for stocks that are poised to beat at earnings season and Sorrento T...
Bankrupt Sorrento Therapeutics Secures Court Approval for $75M Financing
Sorrento Therapeutics Inc (NASDAQ: SRNE) announced that the U.S. Bankruptcy Court for the Souther...
An Update On Sorrento: Hitting Rock Bottom And Finding A Shovel (NASDAQ:SCLX)
One should note that Sorrento Therapeutics has been involved in multiple legal actions with Dr....
Why Frequency Therapeutics Are Trading Lower By 82%? Here Are Other Stocks Moving In Monday's...
Why Frequency Therapeutics Are Trading Lower By 82%? Here Are Other Stocks Moving In Monday's...
Sorrento Therapeutics Stock Nosedives After Filing Bankruptcy Paperwork
COVID-19 drug and vaccine developer Sorrento Therapeutics Inc (NASDAQ: SRNE) is filing for bankru...
Sorrento Therapeutics Files for Bankruptcy to Halt $173 Million Licensing Judgments
The biopharmaceutical company filed for chapter 11 to halt the collection of judgments by affilia...
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.11%
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.11%
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.11%
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.11%
ImmunityBio: Upcoming PDUFA, Solid Data, Confusing Finances (NASDAQ:IBRX)
ImmunityBio, Inc. (NASDAQ:IBRX) is another Patrick Soon-Shiong company, one of the relatively mor...
Sorrento Touts Positive Early-Stage Trial Data From Oral COVID-19 Therapy
Sorrento Therapeutics Inc (NASDAQ: SRNE) released topline Phase 2 SAD/MAD study data of its oral ...